Rapport Therapeutics (RAPP) EPS (Basic) (2023 - 2026)
Rapport Therapeutics (RAPP) posted quarterly EPS (Basic) of -$0.42 for Q1 2026, up 38.39% year-over-year from -$0.3 in Q1 2025, and up 51.52% quarter-over-quarter from -$0.87 in Q4 2025.
Rapport Therapeutics (RAPP) EPS (Basic) (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has reported EPS (Basic) for 4 consecutive years, with -$0.42 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 38.39% year-over-year to -$0.42; the TTM figure through Mar 2026 stood at -$2.27 (changed 0.49% YoY), while the FY2025 annual figure was -$2.86, up 24.17% from the prior year.
- EPS (Basic) improved to -$0.42 in Q1 2026 per RAPP's latest filing, from -$0.87 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.42 in Q1 2026 and bottomed at -$11.07 in Q1 2024.
- Historically, EPS (Basic) has averaged -$3.07 across 4 years, with a median of -$0.92 in 2024.
- On a YoY basis, EPS (Basic) climbed as much as 93.84% in 2025 and fell as far as 41.08% in 2025.
- Rapport Therapeutics' EPS (Basic) stood at -$8.98 in 2023, then jumped by 89.27% to -$0.96 in 2024, then rose by 9.99% to -$0.87 in 2025, then soared by 51.52% to -$0.42 in 2026.
- Business Quant data shows RAPP's EPS (Basic) at -$0.42 in Q1 2026, -$0.87 in Q4 2025, and -$0.71 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Rapport Therapeutics | 2.27 Bn | 2.27 Bn | - | -1.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.19 |
| Mar 31, 2026 | -0.42 |
| Dec 31, 2025 | -0.87 |
| Sep 30, 2025 | -0.71 |
| Jun 30, 2025 | -0.75 |
| Mar 31, 2025 | -0.68 |
| Dec 31, 2024 | -0.96 |
| Sep 30, 2024 | -0.50 |
| Jun 30, 2024 | -1.70 |
| Mar 31, 2024 | -11.07 |
| Dec 31, 2023 | -8.98 |
| Sep 30, 2023 | -5.70 |
| Jun 30, 2023 | -4.45 |